Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1/2 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 24Colorectal Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Neoplasms 18Recurrence 16Pancreatic Neoplasms 16Multiple Myeloma 15Prostatic Neoplasms 13Advanced Solid Tumors 12Carcinoma, Hepatocellular 11Stomach Neoplasms 10Leukemia, Myeloid, Acute 10Advanced Solid Tumor 10Ovarian Neoplasms 9Triple Negative Breast Neoplasms 8Small Cell Lung Carcinoma 7Squamous Cell Carcinoma of Head and Neck 6Neoplasm Metastasis 6Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Head and Neck Neoplasms 6Glioblastoma 6Urinary Bladder Neoplasms 5Solid Tumors 5Lymphoma, B-Cell 5Lung Neoplasms 5Liver Neoplasms 5Glioma 5Uterine Cervical Neoplasms 4Lymphoma 4

Interventions

Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Not yet recruiting × Cognitive Dysfunction × Clear all
NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

University of California, Irvine

Phase 1/2 Not yet recruiting
102 enrolled
Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡